- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
This is a Virtual Event for PsychU members in Alabama and Tennessee.
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.
FEATURING
Beau Pender, PharmD (OPDC)
Clinical & Scientific Liaison
Jason Carter, PharmD (OPDC)
Clinical & Scientific Liaison
Speakers Beau Pender, PharmD and Jason Carter, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
June 3 12:00 pm to 1:00 pm -
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
June 3 7:00 pm to 8:00 pm -
Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses
June 7 7:00 pm to 8:00 pm
Registration
Related Resources
-
Re-Imagining The Dopamine Hypothesis Of Schizophrenia: How Can We Find A Balance?
On-Demand Webinar May 24, 2022The dopamine hypothesis of schizophrenia has been foundational in elucidating the benefit of dopamine-blocking actions of antipsychotic medications over the past 60 years. Although blocking the D2 receptors may lead…
-
16% Of Community Mental Health Centers Use Measurement-Based Care, Despite Knowledge Of Value
Article May 23, 2022As of October 2021, 83% of community mental health center (CMHC) executives said that “their organization is familiar with the value of using measurement-based care (MBC)”, however just 16% were…
-
New Florida Law Exempts Antipsychotics From Medicaid Step Therapy
Article May 23, 2022On April 6, 2022, Florida enacted a bill to exempt Medicaid beneficiaries diagnosed with schizophrenia from step-therapy authorizations for antipsychotic medications. Under the new law, the beneficiary can be exempted…
Stay Connected:
- Resource Library